What is the recommended starting order for high flow oxygen therapy (High Flow Oxygen Therapy) in patients requiring it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Order for High-Flow Oxygen Therapy

For patients requiring high-flow oxygen therapy, start with a flow rate of 60 L/min and FiO2 of 0.6 (60%), then titrate based on SpO2 response and clinical parameters. 1

Initial Flow Rate Selection

Begin with 60 L/min as the starting flow rate for high-flow nasal oxygen (HFNO) therapy, as this provides superior outcomes compared to lower initial flows. 1

  • In cardiac surgery patients with hypoxemia, an initial flow of 60 L/min resulted in 2.4-3.9 times higher probability of achieving SpO2 >92% and respiratory rate 12-20 breaths/min compared to 40 L/min or conventional oxygen. 1
  • The 60 L/min starting flow demonstrated lower hazard for treatment failure (HR 0.11) compared to conventional oxygen therapy. 1
  • While 40 L/min also showed benefit over conventional therapy (HR 0.30), the 60 L/min flow was superior for achieving target oxygenation and respiratory rate parameters. 1

Initial FiO2 Setting

Set initial FiO2 at 0.6 (60%) as the standard starting point, which can then be titrated to achieve target saturations. 1

  • This starting FiO2 allows room for both upward and downward titration based on patient response. 1
  • The British Thoracic Society guidelines support high-flow oxygen as an alternative to reservoir mask treatment in acute respiratory failure without hypercapnia. 2

Target Saturation Ranges

Target SpO2 94-98% for most patients without risk of hypercapnic respiratory failure. 2

Target SpO2 88-92% for patients with COPD or other risk factors for hypercapnic respiratory failure (morbid obesity, cystic fibrosis, chest wall deformities, neuromuscular disorders, fixed airflow obstruction with bronchiectasis). 2

Titration Protocol

Allow at least 5 minutes at each setting before making further adjustments, except when saturation falls suddenly by ≥3%. 2

  • Monitor SpO2, respiratory rate, heart rate, blood pressure, and mental status continuously during initiation. 3
  • Adjust FiO2 first to achieve target saturation, maintaining flow rate at 60 L/min initially. 1
  • If target saturation cannot be achieved at FiO2 1.0 (100%) and 60 L/min, seek senior medical input immediately and consider escalation to non-invasive ventilation or intubation. 2

Critical Monitoring Parameters

Respiratory rate >30 breaths/min requires immediate intervention even if SpO2 appears adequate, as this indicates respiratory distress. 3

  • Obtain arterial blood gases within 1 hour if increased oxygen requirements develop. 2
  • Reassess blood gases after 30-60 minutes in patients at risk for hypercapnic respiratory failure. 2
  • A sudden fall in SpO2 of ≥3% requires clinical reassessment even if saturation remains within target range. 2

Important Caveats

High-flow oxygen does not guarantee accurate FiO2 delivery when patient inspiratory flow exceeds device flow. 4

  • At peak inspiratory flows of 60-120 L/min (common in acute respiratory failure), the actual inspired FiO2 may be significantly lower than the set FiO2. 4
  • This variability is most pronounced when patient inspiratory flow exceeds the set device flow, emphasizing the importance of starting at 60 L/min rather than lower flows. 4

Patients on high-flow oxygen are critically ill and require continuous monitoring with capability for immediate escalation to invasive ventilation. 5

When NOT to Use High-Flow Oxygen

Avoid high-flow oxygen as first-line therapy in hypercapnic respiratory failure with respiratory acidosis—use non-invasive ventilation instead. 5, 6

  • In acute-on-chronic respiratory failure with acidosis, NIV is clearly superior. 6
  • High-flow oxygen data in hypercapnic failure are inconclusive and NIV should be preferred. 5

Weaning Considerations

Reduce FiO2 first while maintaining flow rate if patient is stable and SpO2 is in the upper target range for 4-8 hours. 3

  • Once FiO2 is reduced to 0.4 (40%) or less with stable saturations, consider transitioning to conventional oxygen delivery. 3
  • Discontinue oxygen therapy only when patient maintains target saturation on room air on two consecutive observations. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.